SignatureFD’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
HWAM
SOADOR
LSERS
DT
MFG
PFSRSONJ
YCM
AB
SignatureFD's ACAD Position: Q2 2026 in Review
SignatureFD increased its Acadia Pharmaceuticals (ACAD) stake by 59% in Q2 2026, buying an estimated $2.24K and bringing the position to 276 shares worth $6.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2769.
SignatureFD first reported a position in ACAD in Q2 2020 and has held it in 20 quarters since. The position peaked at $10K in Q2 2021. 53 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.
- SignatureFD held 276 shares of Acadia Pharmaceuticals worth $6.98K as of Q2 2026.
- SignatureFD bought 102 Acadia Pharmaceuticals shares in Q2 2026, an estimated $2.24K.
- Acadia Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2769 holding.
- SignatureFD first reported a position in Acadia Pharmaceuticals in Q2 2020 and has held it in 20 quarters since.
- SignatureFD's Acadia Pharmaceuticals position peaked at $10K in Q2 2021.
- 53 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.